Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 0 | 0 | 0 | 500 | 0 |
| Gross Profit | 0 | 0 | N/A | 500 | N/A |
| Operating Expenses | 7,130 | 9,010 | 0 | 5,590 | 0 |
| Operating Income | -7,130 | -9,010 | N/A | -5,090 | N/A |
| Interest Expense | 310 | 60 | 0 | 60 | 0 |
| Other Income | 1,140 | 200 | 0 | -2,760 | 0 |
| Pre-tax Income | -6,300 | -8,870 | 0 | -7,910 | 0 |
| Income Tax | 6 | 3 | N/A | 50 | N/A |
| Net Income Continuous | -6,571 | -8,369 | N/A | -7,145 | N/A |
| Net Income | $-6,300 | $-8,870 | $N/A | $-7,960 | $N/A |
| EPS Basic Total Ops | -104.95 | -182.91 | N/A | -253.37 | N/A |
| EPS Basic Continuous Ops | -104.97 | -183.13 | N/A | -252.47 | N/A |
| EPS Diluted Total Ops | -104.95 | -182.91 | N/A | -251.87 | N/A |
| EPS Diluted Continuous Ops | -104.97 | -183.13 | N/A | -252.47 | N/A |
| EBITDA(a) | $-7,130 | $-9,000 | $N/A | $-5,030 | $N/A |